Summary:
A research study evaluating blood samples collected from lung cancerand pulmonary nodule patients to assist in future diagnostic test development
Qualified Participants Must:
Be between 35 and 79 years of age
Have Pulmonary Nodules or Lung Cancer
Have been scheduled for a lung biopsy or other diagnostic procedure due to suspicion of lung cancer, or have had a recent CT scan showing a pulmonary nodule > 4mm
Do not have a prior history of cancer (with the exception of non-melanoma skin cancer)
Have not had prior removal of the lung (with the exception of lung biopsies)
Have not received any cytotoxic therapy, such as chemotherapy or radiation therapy
Qualified Participants May Receive:
Financial compensation may be provided for time and travel expenses.
Patent commitment duration: Single visit
Number of visits in study: Single visit